Geocann’s VESIsorb® cannabidiol formulation delivers superior pharmacokinetic performance in published study
14 avr. 2020 12h00 HE
|
Geocann
FORT COLLINS, Colo., April 14, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the peer-reviewed journal, Molecules, has published the results of a double-blind, cross-over study...